Kang Cong Bao, Hong Ye, Dhe-Paganon Sirano, Yoon Ho Sup
School of Biological Science, Nanyang Technological University, Singapore, Singapore.
Neurosignals. 2008;16(4):318-25. doi: 10.1159/000123041. Epub 2008 Jul 18.
Immunophilins consist of a family of highly conserved proteins binding with immunosuppressive drugs such as FK506, rapamycin and cyclosporin A. FK506-binding protein (FKBP) is one of two major immunophilins and most of FKBP family members bind FK506 and show peptidylprolyl cis/trans isomerase (PPIase) activity. Small size FKBP family members contain only FK506-binding domain, while FKBPs with large molecular weights possess extra domains such as tetratricopeptide repeat domains, calmodulin binding and transmembrane motifs. FKBPs are involved in several biochemical processes including protein folding, receptor signaling, protein trafficking and transcription. FKBP family proteins play important functional roles in the T-cell activation, when complexed with their ligands. The roles of immunophilins in protein transportation and apoptosis through their molecular interactions with receptors or proteins have emerged recently. Moreover, therapeutic implications of immunophilin ligands in treating neurodegenerative disorders have been accumulating. FK506 and its derivatives with no immunosuppressive activities bind to the conserved active sites of the canonical FKBP members such as FKBP12, which shows PPIase activity. These immunophilin ligands show variable efficacy in animal models for Parkinson's disease, dementia, and spinal cord injury, where the canonical immunophilins function as chaperones and are associate with the protein folding and modulation of oxidative stress. On the other hand, in the noncanonical FKBP members such as FKBP38, FK506-binding site is not conserved and shows neither PPIase activity nor affinity to FK506. Interestingly, the small molecule-mediated inhibition of the noncanonical member of FKBP family appears to cause neuronal protection and induce proliferation of neuronal stem cells in a rat focal cerebral ischemia model. Currently, the mechanisms of actions remain unclear. This review focuses on molecular characteristics of the canonical and noncanonical FKBP family members and the biological functions of their ligands in performing neuroprotective and neurotrophic activities.
免疫亲和素由一类高度保守的蛋白质组成,它们可与免疫抑制药物如FK506、雷帕霉素和环孢素A结合。FK506结合蛋白(FKBP)是两种主要的免疫亲和素之一,大多数FKBP家族成员可结合FK506并表现出肽基脯氨酰顺/反异构酶(PPIase)活性。小尺寸的FKBP家族成员仅包含FK506结合结构域,而分子量较大的FKBP则拥有额外的结构域,如四肽重复结构域、钙调蛋白结合结构域和跨膜基序。FKBP参与多种生化过程,包括蛋白质折叠、受体信号传导、蛋白质运输和转录。当与配体结合时,FKBP家族蛋白在T细胞活化中发挥重要的功能作用。免疫亲和素通过与受体或蛋白质的分子相互作用在蛋白质运输和细胞凋亡中的作用最近才被发现。此外,免疫亲和素配体在治疗神经退行性疾病方面的治疗意义也在不断积累。无免疫抑制活性的FK506及其衍生物可结合到典型FKBP成员(如具有PPIase活性的FKBP12)的保守活性位点上。这些免疫亲和素配体在帕金森病、痴呆和脊髓损伤的动物模型中显示出不同的疗效,其中典型免疫亲和素起伴侣作用,并与蛋白质折叠和氧化应激调节相关。另一方面,在非典型FKBP成员(如FKBP38)中,FK506结合位点不保守,既不表现出PPIase活性,也不与FK506具有亲和力。有趣的是,在大鼠局灶性脑缺血模型中,小分子介导的对FKBP家族非典型成员的抑制似乎可导致神经元保护并诱导神经干细胞增殖。目前,其作用机制尚不清楚。本综述重点关注典型和非典型FKBP家族成员的分子特征及其配体在发挥神经保护和神经营养活性方面的生物学功能。